Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten …

MA Hlatky, DB Boothroyd, DM Bravata, E Boersma… - The lancet, 2009 - thelancet.com
Background Coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI)
are alternative treatments for multivessel coronary disease. Although the procedures …

A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C

LI Backus, DB Boothroyd, BR Phillips, P Belperio… - Clinical …, 2011 - Elsevier
Background & Aims The effectiveness of hepatitis C virus (HCV) treatment with pegylated
interferon and ribavirin usually is evaluated by the surrogate end point of sustained virologic …

[HTML][HTML] The anatomy of the posterior communicating artery as a risk factor for ischemic cerebral infarction

…, IM Johnstone, DB Boothroyd… - … England Journal of …, 1994 - Mass Medical Soc
Background After the occlusion of an internal carotid artery the principal source of collateral
flow is through the arteries of the circle of Willis, but the size and patency of these arteries …

[HTML][HTML] A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients

…, SA Hunt, I Johnstone, DB Boothroyd… - … England Journal of …, 1993 - Mass Medical Soc
Background Accelerated coronary artery disease is a major cause of late morbidity and mortality
among heart-transplant recipients. Because calcium-channel blockers can suppress diet…

Clinical outcomes and cost-effectiveness of fractional flow reserve–guided percutaneous coronary intervention in patients with stable coronary artery disease: three …

WF Fearon, T Nishi, B De Bruyne, DB Boothroyd… - Circulation, 2018 - Am Heart Assoc
Background: Previous studies found that percutaneous coronary intervention (PCI) does not
improve outcome compared with medical therapy (MT) in patients with stable coronary …

[PDF][PDF] Predictors of response of US veterans to treatment for the hepatitis C virus

LI Backus, DB Boothroyd, BR Phillips, LA Mole - Hepatology, 2007 - Wiley Online Library
The currently recommended treatment for hepatitis C virus (HCV) infection is pegylated
interferon alfa (PEG‐INF) and ribavirin, which can be difficult to tolerate. More information about …

Beta-blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease

…, TI Chang, D Kazi, MD Solomon, DB Boothroyd… - Journal of the American …, 2014 - jacc.org
Background : The effectiveness of beta-blockers for preventing cardiac events has been
questioned for patients who have coronary heart disease (CHD) without a prior myocardial …

Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease

MA Hlatky, T Quertermous, DB Boothroyd, JR Priest… - American heart …, 2007 - Elsevier
BACKGROUND: Only some patients with coronary artery disease (CAD) develop acute
myocardial infarction (MI), and emerging evidence suggests vulnerability to MI varies …

Cost-effectiveness of genotype-guided and dual antiplatelet therapies in acute coronary syndrome

…, C Rhee, S Moshkevich, DB Boothroyd… - Annals of internal …, 2014 - acpjournals.org
Background: The choice of antiplatelet therapy after acute coronary syndrome (ACS) is
complicated: Ticagrelor and prasugrel are novel alternatives to clopidogrel, patients with some …

Cost-effectiveness of percutaneous coronary intervention in patients with stable coronary artery disease and abnormal fractional flow reserve

WF Fearon, D Shilane, NHJ Pijls, DB Boothroyd… - Circulation, 2013 - Am Heart Assoc
Background— The Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME)
2 trial demonstrated a significant reduction in subsequent coronary revascularization …